News

  • 07 July 2014
    Diabetes treatment in the United States could be due for some radical change now that the FDA has approved MannKind Corp.’s Afrezza fast-acting, inhalable insulin. Valencia, CA–based MannKind announced the approval late last week. Type 1 diabetics...
  • 07 July 2014
    Antibiotic resistance has been selected as the focus for a £10m prize set up to tackle a major challenge of our time. Six themes were initially identified by organisers of the Longitude Prize; these were then put to a public vote.  The winning theme was...
  • 07 July 2014
    Undergraduate bioengineering students at Johns Hopkins University in Maryland have developed a lightweight defibrillator ‘shirt.' The shirt could potentially allow patients at high risk of cardiac arrest or serious arrhythmias to wear a user-friendly,...
  • 07 July 2014
    The row over NHS England's big data programme - care.data - refuses to die down after the British Medical Association waded into the debate by demanding the scheme be explicitly opt-in only when it is rolled out. During the BMA’s annual representative...
  • 07 July 2014
    A lack of access to real-time patient information is affecting the ability of 88% of community health workers to perform their roles, according to a study of 17 healthcare organisations throughout the UK. The research, undertaken by mobile solutions provider,...
  • 07 July 2014
    The Royal College of Surgeons and Age UK looked at surgery rates for six common procedures for English over-65s. It found a wide variation in access to treatment depending on where people lived and a "worrying" difference between the over 65s and over...
  • 07 July 2014
    Researchers believe that we may be one step closer to being able to use 3D-printed tissue in organ transplant surgery. Over the last year or so we've seen a remarkable number of situations in which 3D printing technology has been deployed in the medical world...
  • 03 July 2014
    Giant healthcare conglomerate Johnson & Johnson has announced that it has completed the sale of its Ortho-Clinical Diagnostics (OCD) business to The Carlyle Group for approximately $4 billion. In conjunction with the sale of OCD, Robert Yates will assume the...
  • 03 July 2014
    The National Institute for Health and Care Excellence (NICE) said it will cover Johnson & Johnson subsidiary Janssen-Cilag’s diabetes drug Invokana (canagliflozin) as a treatment for people with type 2 Diabetes. The decision, which will allow the drug to...
  • 03 July 2014
    GPs could see themselves performance-managed by colleagues, after NHS England revealed plans for CCGs to ‘monitor contractual performance’ and negotiate PMS contracts. According to newly released board papers, 183 of England’s 211 CCGs have...
RSS feed

http://www.medilinkuk.com/sites/default/files/uploads/UK-LifeScience-Industry-Magazine-advert_7.jpg

citizenaid.jpg